As of 2026-02-13, the Relative Valuation of Adicet Bio Inc (ACET) is (156.16) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.81 USD, the upside of Adicet Bio Inc based on Relative Valuation is -2393.1%.
The range of the Relative Valuation is (145.75) - (161.06) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 17.2x | 15.8x |
| Forward P/E multiples | 13.9x - 15.8x | 14.8x |
| Fair Price | (145.75) - (161.06) | (156.16) |
| Upside | -2240.2% - -2465.0% | -2393.1% |
| Date | P/E |
| 2026-02-11 | -0.66 |
| 2026-02-10 | -0.70 |
| 2026-02-09 | -0.71 |
| 2026-02-06 | -0.69 |
| 2026-02-05 | -0.63 |
| 2026-02-04 | -0.73 |
| 2026-02-03 | -0.75 |
| 2026-02-02 | -0.78 |
| 2026-01-30 | -0.78 |
| 2026-01-29 | -0.83 |
| 2026-01-28 | -0.83 |
| 2026-01-27 | -0.84 |
| 2026-01-26 | -0.85 |
| 2026-01-23 | -0.83 |
| 2026-01-22 | -0.82 |
| 2026-01-21 | -0.79 |
| 2026-01-20 | -0.77 |
| 2026-01-16 | -0.81 |
| 2026-01-15 | -0.78 |
| 2026-01-14 | -0.81 |
| 2026-01-13 | -0.81 |
| 2026-01-12 | -0.77 |
| 2026-01-09 | -0.79 |
| 2026-01-08 | -0.79 |
| 2026-01-07 | -0.83 |
| 2026-01-06 | -0.79 |
| 2026-01-05 | -0.80 |
| 2026-01-02 | -0.86 |
| 2025-12-31 | -0.82 |
| 2025-12-30 | -0.78 |
| 2025-12-29 | -0.77 |
| 2025-12-26 | -0.82 |
| 2025-12-24 | -0.81 |
| 2025-12-23 | -0.76 |
| 2025-12-22 | -0.77 |
| 2025-12-19 | -0.77 |
| 2025-12-18 | -0.74 |
| 2025-12-17 | -0.74 |
| 2025-12-16 | -0.73 |
| 2025-12-15 | -0.78 |
| 2025-12-12 | -0.78 |
| 2025-12-11 | -0.81 |
| 2025-12-10 | -0.86 |
| 2025-12-09 | -0.84 |
| 2025-12-08 | -0.82 |
| 2025-12-05 | -0.84 |
| 2025-12-04 | -0.87 |
| 2025-12-03 | -0.84 |
| 2025-12-02 | -0.88 |
| 2025-12-01 | -0.96 |